newsfilter
← Latest News
GlobeNewswire·

LianBio Announces Mavacamten Granted Breakthrough Therapy Designation in China

SHANGHAI and PRINCETON, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) -- LianBio (NASDAQ:LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that the Center for Drug Evalu